Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-08-000300
Filing Date
2008-04-07
Accepted
2008-04-07 16:47:25
Documents
3
Period of Report
2008-04-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o40022e6vk.htm 6-K 286100
2 GRAPHIC o40022o4002201.gif GRAPHIC 4466
3 GRAPHIC o40022o4002202.gif GRAPHIC 11112
  Complete submission text file 0001130319-08-000300.txt   309289
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 08743393
SIC: 2834 Pharmaceutical Preparations